| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |